SALEEM A ALI

Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry COLUMBUS, MS NPI 1801989124

General Payments — all program years on this page

$829.55

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 51
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $167.75 across 11 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $167.7511

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
ITI, Inc. $72.685
ABBVIE INC. $58.704
Teva Pharmaceuticals USA, Inc. $36.372

By program year

Program yearAmountRecords
2018 $62.523
2019 $39.532
2021 $81.364
2022 $196.1512
2023 $282.2419
2024 $167.7511

Records — PY2024 (11)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1103204111 ABBVIE INC. $14.20 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103204113 ABBVIE INC. $17.01 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103204115 ABBVIE INC. $13.16 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103204117 ABBVIE INC. $14.33 08/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143182554 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $14.55 01/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143182557 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $15.78 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143182561 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $15.06 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143182564 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $13.29 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143182568 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $14.00 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151506524 Teva Pharmaceuticals USA, Inc. $18.61 01/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151506572 Teva Pharmaceuticals USA, Inc. $17.76 03/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.